NCT04567628View on ClinicalTrials.gov

Study of Relationship Between Vedolizumab Therapeutic Drug Monitoring, Biomarkers of Inflammation and Clinical Outcomes

CompletedOBSERVATIONAL
Enrollment

7,873

Participants

Timeline

Start Date

October 5, 2020

Primary Completion Date

September 22, 2021

Study Completion Date

September 22, 2021

Conditions
Inflammatory Bowel DiseasesColitis, UlcerativeCrohn Disease
Interventions
OTHER

No Intervention

As this was an observational study, no intervention was administered.

Trial Locations (1)

ON M5H 4E3

Takeda Canada, Toronto

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT04567628 - Study of Relationship Between Vedolizumab Therapeutic Drug Monitoring, Biomarkers of Inflammation and Clinical Outcomes | Biotech Hunter | Biotech Hunter